As part of our monthly news service we would like to make you aware of the CML publications of the month. From the many papers published every month Professor Timothy Hughes has selected topical, interesting papers for your perusal that also include interesting articles from the emerging economic regions and publications on COVID-19 and CML.

Read Professor Hughes' CML publications of the month: February 2023

Clinical papers

• Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modelling and pathway analysis
  Radich JP et al. Haematologica, February 2023 (epub ahead of print) – open access publication
• Family planning and pregnancy in patients with chronic myeloid leukemia – Review
  Berman E et al. Curr Hematol Malig Rep, February 2023 (epub ahead of print)
• Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison
  Hyland KA et al. Leuk Lymphoma, February 2023
• Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network
  Nunes RAB et al. Front Cardiovasc Med, February 2023 – open access publication
• Importance of tyrosine kinase inhibitor treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-Free study
  Yoshida C et al. Int J Hematol, February 2023 (epub ahead of print) – open access publication
  
• A survey of patient experience in CML: American and Canadian Perspectives
  Hillis C et al. Patient Prefer Adherence, February 2023 – open access publication

Scientific papers

• The bone marrow immune environment in CML: Treatment responses, treatment-free remission and therapeutic vulnerabilities
  Patterson SD & Copland M. Curr Hematol Malig Rep, February 2023 (epub ahead of print) – open access publication
  

Pediatric CML papers

• Recent progress in the management of pediatric chronic myeloid leukemia
  Shima H & Shimada H. Int J Hematol, February 2023 – open access publication

ERSAP papers

• Attenuated dose dasatinib in newly diagnosed chronic myeloid leukemia chronic phase patients in India
  Ahmed R et al. Clin Lymphoma Myeloma Leuk, February 2023